A commercial polyclonal antibody directed against the C-terminus of GRP78 was reported to induce apoptosis in melanoma cells (A375) and prostate cancer cells (1-LN, DU145) but not in the PC-3 prostate cancer cell line. This evidence concerns the gene HSPA5 and prostate carcinoma.